1.30 closing is closer now

Bintai can do better TP today 1.30

This is a Vaccine month, more to come

However, analysts believe the sudden share price movement after about two months of continued decline could just be a “bounce”, rather than a short-term upward reversal.
With the increased positive newsflow on Covid-19 vaccines, glove stocks’ position as the darlings of the Malaysian stock market may take further hit.
The United Kingdom had begun rolling out the Pfizer-BioNTech vaccine for mass inoculation.
Within the region, Indonesia has received the first batch of vaccines from China’s Sinovac Biotech as the government prepares a mass vaccination programme.
Moving forward, analysts expect investors to be more focused on the recovery play stocks and at the same time, reducing their exposure to the glove stocks.
This is despite the fact that domestic Covid-19 infections remain high with mostly four digit daily cases in the recent weeks.

However, analysts believe the sudden share price movement after about two months of continued decline could just be a “bounce”, rather than a short-term upward reversal.
With the increased positive newsflow on Covid-19 vaccines, glove stocks’ position as the darlings of the Malaysian stock market may take further hit.
The United Kingdom had begun rolling out the Pfizer-BioNTech vaccine for mass inoculation.
Within the region, Indonesia has received the first batch of vaccines from China’s Sinovac Biotech as the government prepares a mass vaccination programme.
Moving forward, analysts expect investors to be more focused on the recovery play stocks and at the same time, reducing their exposure to the glove stocks.
This is despite the fact that domestic Covid-19 infections remain high with mostly four digit daily cases in the recent weeks.

Tourist from China, singapore and etc are still not permitted to enter Malaysia yet and count on local only yet not in full capacity operation.

maybe, the covid 19 continue, it will drag until end of this year. the next quarter will not also be so promising.

genting only operates 25% of the capacity only for time being and the table is very limted for few person.

malaysia hv 30 million population and everyone shd be injected to break the chain of infection. and vaccine is not only for patient la

Either USA, China or Russian Vaccine approved, it will confirm bottle by D pharma or Pharma niaga whichbthe facilitu is ready and standby, cheers

dpharma facility is already stand by once the vaccines approved.

Last month, Science, Technology and Innovation Minister Khairy Jamaluddin said the government had agreed for the facilities owned by Duopharma Biotech Bhd and Pharmaniaga to be used for the bottling of the vaccine.
The largest pharmaceutical company registered a 3.7% increase in net profit to RM9.61mil for the second quarter ended June 30,2020 compared to a year ago.
This was achieved on the back of a turnover of RM646mil, from higher sales of personal protective equipment due to the ongoing pandemic.
Net profit for the first half of the financial year rose 10.8% to RM32.02mil, as compared to the same period last year.

Soon will be the Vaccine trend, buckle up.

both company is classify as a GLC COMPANIES, sure will be taken care of.

vaccines just a matter of time, and is time to accumulate Dpharma and Pharma niaga before is too late.

KUALA LUMPUR: Pharmaniaga Bhd says it is all geared up to make the necessary changes to its existing plants that will enable it to undertake fill and finish process for Covid-19 vaccine as soon as it is developed, acting managing director Mohamed Iqbal Abdul Rahman said.

 

He said the group had presented to the National Science Council its plan, capacity and capabilities for the purpose.

 

"This is part of the short-term plan of the group in addressing the urgent need for the Covid-19 vaccine," he told Bernama in a written reply when asked on Pharmaniaga's future plans.

 

Last month, Science, Technology and Innovation Minister Khairy Jamaluddin said the government had agreed that the facilities owned by Duopharma Biotech Bhd and Pharmaniaga be used for bottling the vaccine.

 

Khairy reportedly explained that the two companies were chosen as both are government-linked - Duopharma is owned by Permodalan Nasional Bhd and Pharmaniaga is owned by Boustead Holdings Bhd — and currently have unused capacity that can be directed towards this purpose.

 

Mohamed Iqbal said Pharmaniaga, Malaysia's largest pharmaceutical company, was on track to establish the world's first halal vaccine facility, targeted for completion by 2022.

 

"In 2018, Pharmaniaga announced plans to establish a vaccine plant. We have since completed conducting the necessary due diligence and secured partnerships with international vaccine producers," he said.

 

In addition, Pharmaniaga has long-term plans for sustainable growth and has put in place six strategic thrusts to drive the company to the next level.

 

As a government-linked company, Pharmaniaga is committed to continuously provide the highest standard of service to allow the Ministry of Health to focus on healthcare delivery, with Pharmaniaga as its preferred logistics partner.

 

"Although we have secured a logistics and distribution contract until November 2024, we are hopeful that our proven track record, ready infrastructure, integrated information technology, and most importantly, experienced human capital, will position us well to secure a potential extension following this period," he said.

 

Mohammed Iqbal said Pharmaniaga also benefitted significantly from the group's digitalisation efforts over the past few years, ensuring minimal disruptions during the Movement Control Order (MCO) period.

 

Pharmaniaga will also be expanding its product portfolio with new products to be manufactured in-house, as well as strengthen its agency and distributorship segment and expand its one-stop centre facilitation.

 

"With over 300 alliances and more than 6,000 private hospitals, general practitioners and pharmacy outlets, Pharmaniaga has a very strong base to build on and further strengthen customer loyalty," he said.

 

The group will continue to equip its employees with the necessary training and support to comply with all regulatory and statutory requirements.

 

"With a workforce of more than 3,500, our human capital is our most valuable asset. We are also committed to prioritising local employment, with a workforce comprising 99.5 per cent locals, supported by specialised international talent mainly in our research and development team.

 

"We are also adapting to the 'new normal' post- Covid-19 and harnessing positive learnings from the MCO. Online meetings and work from home have given us the opportunity to 'do more for less' as we have less travelling cost and more productive time," he added.

 

For the six months ended June 30, 2020, Pharmaniaga recorded a net profit of RM32.38 million compared with RM28.89 million year-on-year (y-o-y), while revenue jumped to RM1.47 billion from RM1.39 billion previously.

 

He said despite recording revenue growth y-o-y, the group's Indonesian operations had been loss-making over the years.

 

During the second quarter of 2020 especially, the Indonesia division recorded a deficit of RM2 million, mainly due to higher finance costs as a result of the delay in payments from government hospitals, currently affecting its healthcare industry.

 

"The division was further impacted by the republic's large-scale social restrictions in response to the Covid-19 pandemic, which resulted in limited access to doctors, clinics, pharmacies and hospitals," it said in a filing to Bursa Malaysia.

 

Mohamed Iqbal said to mitigate this, the company was seeking solutions to manage the delays in payment by government hospitals for the distribution business.

 

As for the manufacturing facility in Bandung, Pharmaniaga had expanded its sales channels, with a view to breaking even in 2021, and hopefully, returning to profitability over the longer term, he added.

 

 - Bernama

Khairy: Govt identifies Pharmaniaga and Duopharma Biotech for Covid-19 vaccine bottling when available
Author: savemalaysia | Publish date: Tue, 14 Jul 2020, 8:45 PM

KUALA LUMPUR, July 14 — Putrajaya has identified two pharmaceutical manufacturing facilities that will be tasked to “fill and finish” Covid-19 vaccines once a cure has been found.
Science, Technology and Innovation Minister Khairy Jamaluddin told reporters at Parliament today that the manufacturing facilities belong to Pharmaniaga and Duopharma Biotech Berhad.
“The two companies have told the government that they are willing to take stock production and prioritise it for the Covid-19 vaccine when it is available. This is how the private sector is working with us to ensure that the vaccine will quickly reach the people.
“If we have the capacity, we will also offer our fill-and-finish service to other countries. We are not developing our own vaccine and we have been told that the bottleneck when it comes to vaccine distribution is at the fill-and-finish level.
“We will purchase the vaccine in bulk, in liquid form before it is dispersed into its respective vials before distribution,” said Khairy.
He said the government is still looking at vaccine research and trials being conducted in China, the United States and the United Kingdom.
He said the government has not decided on which vaccine to purchase as even the ones in China is still undergoing clinical trials.
Khairy added that once the Health Ministry has identified the best vaccine, the government will purchase it and it will be his ministry’s responsibility to have it packaged.
After it has been bottled, the Health Ministry will then begin distribution to the general public.
https://www.malaymail.com/news/malaysia/2020/07/14/khairy-govt-identifies-pharmaniaga-and-duopharma-biotech-for-covid-19-vacci/1884438

Khairy: Govt identifies Pharmaniaga and Duopharma Biotech for Covid-19 vaccine bottling when available
Author: savemalaysia | Publish date: Tue, 14 Jul 2020, 8:45 PM

KUALA LUMPUR, July 14 — Putrajaya has identified two pharmaceutical manufacturing facilities that will be tasked to “fill and finish” Covid-19 vaccines once a cure has been found.
Science, Technology and Innovation Minister Khairy Jamaluddin told reporters at Parliament today that the manufacturing facilities belong to Pharmaniaga and Duopharma Biotech Berhad.
“The two companies have told the government that they are willing to take stock production and prioritise it for the Covid-19 vaccine when it is available. This is how the private sector is working with us to ensure that the vaccine will quickly reach the people.
“If we have the capacity, we will also offer our fill-and-finish service to other countries. We are not developing our own vaccine and we have been told that the bottleneck when it comes to vaccine distribution is at the fill-and-finish level.
“We will purchase the vaccine in bulk, in liquid form before it is dispersed into its respective vials before distribution,” said Khairy.
He said the government is still looking at vaccine research and trials being conducted in China, the United States and the United Kingdom.
He said the government has not decided on which vaccine to purchase as even the ones in China is still undergoing clinical trials.
Khairy added that once the Health Ministry has identified the best vaccine, the government will purchase it and it will be his ministry’s responsibility to have it packaged.
After it has been bottled, the Health Ministry will then begin distribution to the general public.
https://www.malaymail.com/news/malaysia/2020/07/14/khairy-govt-identifies-pharmaniaga-and-duopharma-biotech-for-covid-19-vacci/1884438

Sad to say if the vaccine announce less effectiveness to the Mutate Covid 19, we may need to wear mask till end of Y2021. Sad to say

Nothing is impppsible to Rm3. How promising is the vaccine is a question mark?

Mask is an essential items and we need to replace it everday. Can you see the daily volumes. Covid 19 is not contain uet.

Riding the Storm to limit Up Again and Again

TG and Supermax glove counters roaring, all mask and PPE will back to the glory days and breaking the previuos record high.

Soon be limit uppp Hooray

Not 30% is 30 cents share price below Rm1

if not mistaken the share price less than Rm1 the limit up is increase 30 cents a day

tomolo will up another 25 cents.

A safe vaccine will new at least 2 years to develop according to the medical reliable sources.

Glove, Mask, PPE will be riding the storm to limit up

Hold till Rm3 is a possible not dream

Mask will be an essential item till end of 2021.

Sad to say global infection daily cases is spiking everday, and how promising is the vaccine is still a ? Few cases had been reported the cure patient are reinfected within 3 months an

Covid 19 at moment is not contain, even the vaccine how promising is still a question mark. Some patients are curing from covid reinfect again within 3 months.

Of course will up,Daily infection 60K cases in USA, Brazil, India are spiking everday.

just keep reloading, will spike up again

The numbers are kept increasing, can you imagine how many masks needed for the daily usage.

mask is an essential to stop covid from spreading, vaccine still have a long way, why so panic.

pak tua pls add me in 012 3898907